Skip to content
Recall Observatory FDA recall evidence

Drug product

Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.

D-832-2013

May 20, 2013

Class I

Product summary

Firm
Sandoz Incorporated
Event
Event 65200
Status
Terminated
Classification
Class I
Quantity
1,635 vials
Official record key
drug-enforcement:D-832-2013

Official wording

Reason: Presence of Particulate Matter: Found during examination of retention samples.

Code information: Lot #: CL0996, Exp 12/13; and CJ4948, Exp 05/13

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter